Clinical Trials in Nashville

Showing 3241-3260 of 15,379 trials

OCS DCD Heart + CAP Continued Follow-Up

NCT05741723

The objective of this post-approval study is to evaluate long-term outcomes of patients enrolled in the OCS DCD Heart and OCS DCD Heart CAP studies.

Heart Transplant

TransMedics276 participantsStarted Nov 2019

La Jolla, California, United States • Palo Alto, California, United States • New Haven, Connecticut, United States +17 more locations

RECRUITINGPhase 2< 1 mile

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

NCT05919108

This phase II trial tests how well neratinib prior to the primary treatment (neoadjuvant) works in treating patients with stage I-III HER2 mutated lobular breast cancers. Neratinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Giving neratinib in addition to normal therapy may work better in treating cancer than the endocrine therapy patients would normally receive.

Anatomic Stage I Breast CancerAnatomic Stage II Breast CancerAnatomic Stage III Breast Cancer+1 more

Vanderbilt-Ingram Cancer Center30 participantsStarted May 2024

Atlanta, Georgia, United States • Pittsburgh, Pennsylvania, United States • Nashville, Tennessee, United States +2 more locations

OCS DCD Heart + CAP Continued Follow-Up

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Find Trials by Condition in Nashville

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity

Phase 2b Study of ALTO-100 in MDD

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

International Rare Brain Tumor Registry

Hemorrhagic Myocardial Infarction Detection by Post-reperfusion Troponin Kinetics

ACHIEVE Hearing Intervention Follow-Up Study

Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis

Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Skin Reactions Related to Thoracic Implantable Chamber Dressings